The
theme of International Rare Disease Day 2014 is “Join Together for Better
Care.” As
patients and caregivers who have been
impacted by peritoneal
cancers (Appendix
Cancer, Pseudomyxoma Peritonei, and other
Peritoneal
Surface Malignancies) our
organizations have chosen to join together to share a
simple message about these
diseases.
This year’s Rare Disease Day
Ambassador (http://ow.ly/tQj4T), Sean Hepburn
Ferrer, lost his mother Audrey
Hepburn to peritoneal adenocarcinoma in 1993
at a time when she was offered
precious little treatment or hope. Over 20 years
after Audrey Hepburn’s
experience, one of the greatest challenges with these
diseases continues to
be correct and timely diagnosis and
access to the
Standard of Care:
cytoreductive surgery plus hyperthermic
intraperitoneal
chemotherapy (CRS/HIPEC).
In many cases, symptoms are misunderstood for
years, and patients
are thus less likely to benefit from
CRS/HIPEC. This
treatment, unavailable to
our patient population only a generation
ago, has
turned what used
to be an almost certain death
sentence into hope for
thousands of patients around the
world.
We share the goal that every
patient who presents with the common symptoms
of these diseases – abdominal
pain, increased abdominal girth, bloating, hernia,
ovarian cysts or tumors, and
ascites – receive correct diagnosis through tumor
marker blood tests (CEA, CA 19/9,
CA‐125) and CT scans and
be afforded the
option to be
treated with the Standard of Care,
CRS/HIPEC, by a qualified
surgical oncologist
before any other counterproductive and
potentially
damaging treatments are
attempted.
We all share the hope of
achieving this goal, and by joining together in this
statement and sharing this
information, we strive for future patients suffering
from these diseases to receive
the better care that they deserve.
My scan came out clear!! Yay!!
ReplyDeleteHi Nancy,
ReplyDeleteJust spotted your message. FANTASTIC NEWS! That's really made my day.So pleased for you and the family you must all be very happy indeed.
Best wishes as ever,
Dave